E

Evommune Inc.
D

EVMN

13.860
USD
0.08
(0.58%)
مفتوح الان
حجم التداول
4,919
الربح لكل سهم
-3
العائد الربحي
-
P/E
-1
حجم السوق
503,008,686
المقالات
المزيد

العنوان: Evommune Inc.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.